American Association for Cancer Research

Landon Prizes for Basic and Translational Cancer Research

Nominations for the 2009 Prizes are now open. 

Nomination Deadline Extended!  Friday, September 5, 2008 at 4:00 p.m., U.S. Eastern Time


Learn about the 2008 Prize recipients, Drs. Arnold Levine and John Mendelsohn.

The Prizes

These two major international Prizes were first presented in 2002 to heighten the attention of scientists and members of the general public to landmark scientific achievements in the continuing effort to prevent and cure cancer; to recognize and reward cancer scientists for these extraordinary accomplishments; and to stimulate the development of new thinking and novel concepts in both basic and translational research through the presentation of exciting scientific lectures by the Prize winners, thus inspiring other cancer researchers to uncover the mysteries of this complex disease.

Each Prize consists of US$100,000, consisting of a $15,000 honorarium and an $85,000 grant for direct research expenses, which may be designated for the salary and benefits of postdoctoral fellows.

 

Prize Criteria

  • The Prizes are awarded to outstanding scientists who have made seminal cancer research discoveries at the cutting edge of scientific novelty and significance. Such discoveries must have accelerated progress against cancer and must have implications for future discoveries and contributions to cancer research.
  • The Prizes are intended to honor an individual scientist for his or her research; however, in extraordinary circumstances, two individuals may be selected to share either of these Prizes when their research is closely related in subject matter and has resulted in prize worthy work.

 

Eligibility

  • Candidacy for the Landon-AACR Prizes is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
  • Institutions or organizations are not eligible for the Prizes.
  • Candidates must be active researchers and have a record of recent publications.


Nomination Process

Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.  Candidates may not nominate themselves.

Nomination letters must be sent electronically to awards@aacr.org no later than 4:00 p.m. U.S. Eastern Time on Friday, September 5, 2008.  Preferred file formats are *.doc, *.pdf. Paper nominations will not be accepted.

Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.

The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words.  The content should include the following:

  • the name of the AACR Prize for which the candidate is being nominated; 
  • a brief statement of no more than 50-words summarizing the candidate's cancer research accomplishment(s) for which he or she is being nominated; and
  • describe the candidate's seminal cancer research discoveries with the publications supporting these discoveries directly referenced within the letter. The letter should further explain the impact of the discoveries in terms the contribution of the research to the acceleration of progress against cancer and the implications for future discoveries and contributions to cancer research.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist.  There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

 

Selection

Candidates for the Prizes will be considered by prestigious Committees of renowned international cancer leaders appointed by the President of the AACR. After careful deliberations by the Prize Committees, their recommendations will be forwarded to the Executive Committee of the AACR and the Board of the Landon Foundation for final consideration and decision.

Selection of the Prize winners will be made on the basis of the quality, scientific novelty, innovation, and significance of the basic cancer research (Kirk A. Landon Prize) or translational cancer research (Dorothy P. Landon Prize) of the candidate, the contribution of the research to the acceleration of progress against cancer, and implications for future research. No regard will be given to race, gender, nationality, geographic location, or religious or political views.

 

Responsibilities of Prize Recipients

  • Each of the Prize recipients will present a 50-minute scientific lecture at the 2009 AACR Annual Meeting in Denver, Colorado U.S.A. (April 18-22, 2009) before a large, scientifically diverse audience. In the rare event that there are dual winners of a Prize, the cash award will be shared equally between them, and the AACR Executive Committee will determine which of the two co-recipients will present the Landon-AACR Prize Lecture at the Annual Meeting.
  • The Prize recipients will also participate in the Annual Landon-AACR Prize Symposium and related special events held at the University of Miami/Sylvester Comprehensive Cancer Center in January 2010.

The Kirk A. & Dorothy P. Landon Foundation

landons.jpgThe Kirk A. and Dorothy P. Landon Foundation was created through a bequest from Mrs. Dorothy P. Landon whose intent, along with that of her late husband, Kirk A. Landon, was to dedicate a major portion of their estate to medical research, especially research related to cancer. Mr. R. Kirk Landon, son of Kirk A. Landon, serves as the President of the Foundation. The Foundation seeks to accomplish its cancer research mission through a variety of programs and initiatives, the most important of which are the Landon-AACR Prizes.

 

Questions?

Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA  19106-4404

SPOTLIGHT

2008 Kirk A. Landon-AACR Prize for Basic Cancer Research Winner: Arnold Levine, Ph.D.
Professor, The Cancer Institute of New Jersey
Robert Wood Johnson Medical School-UMDNJ
New Brunswick, NJ
Professor, The Simons Center for System Biology
Institute for Advanced Study
Princeton, NJ

 Levine receiving award

Dr. Levine (center) delivered his Prize lecture entitled, Single Nucleotide Polymorphism in the p53 Pathway, at the  AACR Annual Meeting 2008 in San Diego, CA. He received the Prize from Ms. Nance Guilmartin (right), granddaughter of Kirk A. Landon, and Dr. Lewis C. Cantley (left), Chairperson of the Selection Committee.  The webcast of the Prize lecture may be accessed here.  

 

2008 Dorothy P. Landon-AACR Prize for Translational Cancer Research Winner: John Mendelsohn, M.D.
President
UT M.D. Anderson Cancer Center
Houston, TX

 Mendelsohn receiving award

Dr. Mendelsohn (center) delivered his Prize lecture entitled, Targeting Therapy for Cancer: Accelerating the Pace, at the AACR Annual Meeting 2008 in San Diego, CA. He received Prize from Ms. Nance Guilmartin (left), granddaughter of Kirk A. Landon, and Dr. Stanton L. Gerson (right), Chairperson of the Selection Committee.  The webcast of the Prize lecture may be accessed here.